Contemporary Oncology
eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2025
vol. 29
 
Share:
Share:
abstract:
Original paper

The role of ALKBH5 in regulating proliferation and invasion in U251 glioblastoma cells

Abdul Wahab Jamali
1
,
Zhang Zhanzhan
1
,
Boyu Sun
1
,
Zihan Song
1
,
Arshad Mehmood
2
,
Liqiang Liu
1

  1. Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
  2. Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Contemp Oncol (Pozn) 2025; 29 (2): 195–205
Online publish date: 2025/05/12
View full text Get citation
 
PlumX metrics:
Introduction:
This study aimed to investigate the role of ALKBH5 in the proliferation, invasion, and MUC1 expression of U251 glioblastoma cells, using both in vitro and in vivo methodologies.

Material and methods:
This study investigated the role of ALKBH5, an RNA demethylase, in regulating the proliferation, invasion, and ferroptotic sensitivity of U251 glioblastoma cells, with a focus on its interplay with MUC1, a transmembrane glycoprotein implicated in tumour progression and stress responses.

Results:
Using in vitro and in vivo models, we demonstrate that ALKBH5 knockdown significantly inhibits U251 cell proliferation, invasion, and tumour growth, while its overexpression enhances these oncogenic properties. ALKBH5 regulates MUC1 expression, with MUC1 overexpression that rescues the inhibitory effects of ALKBH5 knockdown on cell viability and invasion. We uncover a novel link between ALKBH5 and ferroptosis, i.e. that ALKBH5 knockdown sensitises U251 cells to ferroptotic cell death through modulation of MUC1-mediated lipid peroxidation and iron metabolism pathways. In vivo studies reveal reduced tumour growth and Ki-67 expression in ALKBH5 knockdown models with decreased MUC1 levels in tumour tissues.

Conclusions:
The results highlight ALKBH5 as a critical regulator of glioblastoma progression and ferroptotic sensitivity, with MUC1 acting as a key downstream effector. Our findings provide new insights into the molecular mechanisms that drive glioblastoma aggressiveness and propose ALKBH5 and MUC1 as promising therapeutic targets for combating this lethal disease.

keywords:

ALKBH5, U251 glioblastoma cells, MUC1 expression, shRNA transfection, Ki-67 expression

Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.